Skip to content

Elecsys HCG+ beta 09744428190Recalls & reported problems

Roche Diagnostics GmbH · Class 2

All models of Elecsys HCG+ beta (2)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 07613336217535), received between Aug 1, 2025 and Nov 24, 2025 — classified as 2 malfunctions.

The most frequently reported specific device problem is “Non Reproducible Results” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 1 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 1 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Non Reproducible Results2
  • High Test Results1
  • Incorrect, Inadequate or Imprecise Result or Readings1
  • Mechanical Problem1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionNov 24, 2025Incorrect, Inadequate or Imprecise Result or Readings; High Test Results; Non Reproducible Results; Incorrect, Inadequate or Imprecise Result or Readings; High Test Results; Non Reproducible Results

    THERE WAS AN ALLEGATION OF A QUESTIONABLE ELECSYS HCG+ BETA RESULT FROM THE COBAS E 801 ANALYTICAL UNIT FOR ONE PATIENT. THE INITIAL RESULT WAS 238 MIU/ML. ON (B)(6) 2025, A NEW SAMPLE WAS COLLECTED WITH THE RESULT OF < 1 MIU/ML. THE INITIAL SAMPLE WAS REPEATED, AND THE RESULT WAS < 1 MIU/ML.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 23636036 ↗
  • MalfunctionAug 1, 2025Mechanical Problem; Non Reproducible Results; Mechanical Problem; Non Reproducible Results

    THERE WAS AN ALLEGATION OF QUESTIONABLE RESULTS FOR 5 PATIENT SAMPLES TESTED FOR ELECSYS HCG+SS (HCG + B) ON TWO COBAS E 801 ANALYTICAL UNITS. (ANALYZER 1 AND ANALYZER 2) DISCREPANT RESULTS FOR 3 PATIENT SAMPLES WERE PROVIDED. PATIENT 1 INITIAL RESULT FROM ANALYZER 2 WAS 0.2 MIU/ML WITH A DATA FLAG. THE REPEAT RESULT WAS 34.5 MIU/ML. PATIENT 2 INITIAL RESULT FROM ANALYZER 2 WAS 0.200 MIU/ML WITH A DATA FLAG. THE REPEAT RESULT WAS 41.7 MIU/ML. ON (B)(6) 2025, PATIENT 3 INITIAL RESULT FROM ANALYZER 1 WAS 0.2 MIU/ML WITH A DATA FLAG. THE REPEAT RESULT WAS 72.7 MIU/ML. THE REPEAT RESULTS WERE BELIEVED TO BE CORRECT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 22686375 ↗

Other SYSTEM, TEST, HUMAN CHORIONIC GONADOTROPIN devices

All SYSTEM, TEST, HUMAN CHORIONIC GONADOTROPIN devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page